| 000 | 01740 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516145225.0 | ||
| 264 | 0 | _c20130724 | |
| 008 | 201307s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1684/bdc.2013.1743 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLagha, Aymen | |
| 245 | 0 | 0 |
_a[Impact of taxanes in the adjuvant setting of node-negative breast cancers]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cMay 2013 |
||
| 300 |
_a465-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 700 | 1 | _aChraiet, Nesrine | |
| 700 | 1 | _aLabidi, Soumaya | |
| 700 | 1 | _aKrimi, Sarra | |
| 700 | 1 | _aAyadi, Mouna | |
| 700 | 1 | _aGligorov, Joseph | |
| 700 | 1 | _aBoussen, Hamouda | |
| 773 | 0 |
_tBulletin du cancer _gvol. 100 _gno. 5 _gp. 465-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1684/bdc.2013.1743 _zAvailable from publisher's website |
| 999 |
_c22695310 _d22695310 |
||